| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ec818dde59a75c3b5b395e29649c2fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D411-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-04 |
| filingDate |
2005-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e8c9fe2627dfae3d1c7ae1e10623505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604c92334b8c968d38fd6658929bdb23 |
| publicationDate |
2008-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080008322-A |
| titleOfInvention |
Process and method for preparing optically active cis-2-hydroxymethyl-4- (cytosine-1'-yl) -1,3-oxathiolane or a pharmaceutically acceptable salt thereof |
| abstract |
The present invention provides a process for the following compound of formula (III) in cis configuration; It also relates to a process for preparing optically active compounds of formula (I) or (II), wherein R 1 , R 2 , R 3 are as defined; It includes methods and processes for the manufacture and recovery and conversion of diastereoisomeric salts. |
| priorityDate |
2005-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |